These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25759023)

  • 1. In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities.
    Rubio-Perez C; Tamborero D; Schroeder MP; Antolín AA; Deu-Pons J; Perez-Llamas C; Mestres J; Gonzalez-Perez A; Lopez-Bigas N
    Cancer Cell; 2015 Mar; 27(3):382-96. PubMed ID: 25759023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seek and destroy: relating cancer drivers to therapies.
    Martinez-Ledesma E; de Groot JF; Verhaak RG
    Cancer Cell; 2015 Mar; 27(3):319-21. PubMed ID: 25759016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer drugs: Advancing precision medicine in silico.
    Cully M
    Nat Rev Drug Discov; 2015 May; 14(5):311. PubMed ID: 25907342
    [No Abstract]   [Full Text] [Related]  

  • 4. In silico analysis of tumors identifies cancer treatment strategies.
    Cancer Discov; 2015 May; 5(5):OF16. PubMed ID: 25813349
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeted therapy in cancer.
    Tsimberidou AM
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated framework for reporting clinically relevant biomarkers from paired tumor/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicine.
    Nasser S; Kurdolgu AA; Izatt T; Aldrich J; Russell ML; Christoforides A; Tembe W; Keifer JA; Corneveaux JJ; Byron SA; Forman KM; Zuccaro C; Keats JJ; Lorusso PM; Carpten JD; Trent JM; Craig DW
    Pac Symp Biocomput; 2015; ():56-67. PubMed ID: 25592568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data.
    Piñeiro-Yáñez E; Reboiro-Jato M; Gómez-López G; Perales-Patón J; Troulé K; Rodríguez JM; Tejero H; Shimamura T; López-Casas PP; Carretero J; Valencia A; Hidalgo M; Glez-Peña D; Al-Shahrour F
    Genome Med; 2018 May; 10(1):41. PubMed ID: 29848362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs.
    van der Velden DL; Hoes LR; van der Wijngaart H; van Berge Henegouwen JM; van Werkhoven E; Roepman P; Schilsky RL; de Leng WWJ; Huitema ADR; Nuijen B; Nederlof PM; van Herpen CML; de Groot DJA; Devriese LA; Hoeben A; de Jonge MJA; Chalabi M; Smit EF; de Langen AJ; Mehra N; Labots M; Kapiteijn E; Sleijfer S; Cuppen E; Verheul HMW; Gelderblom H; Voest EE
    Nature; 2019 Oct; 574(7776):127-131. PubMed ID: 31570881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes.
    Cheng F; Zhao J; Fooksa M; Zhao Z
    J Am Med Inform Assoc; 2016 Jul; 23(4):681-91. PubMed ID: 27026610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
    Do K; O'Sullivan Coyne G; Chen AP
    Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug repurposing in oncology--patient and health systems opportunities.
    Bertolini F; Sukhatme VP; Bouche G
    Nat Rev Clin Oncol; 2015 Dec; 12(12):732-42. PubMed ID: 26483297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trial.
    Tran B; Brown AM; Bedard PL; Winquist E; Goss GD; Hotte SJ; Welch SA; Hirte HW; Zhang T; Stein LD; Ferretti V; Watt S; Jiao W; Ng K; Ghai S; Shaw P; Petrocelli T; Hudson TJ; Neel BG; Onetto N; Siu LL; McPherson JD; Kamel-Reid S; Dancey JE
    Int J Cancer; 2013 Apr; 132(7):1547-55. PubMed ID: 22948899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What have we learned from exceptional tumour responses?: Review and perspectives.
    Mehra N; Lorente D; de Bono JS
    Curr Opin Oncol; 2015 May; 27(3):267-75. PubMed ID: 25811347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems Pharmacology-Based Discovery of Natural Products for Precision Oncology Through Targeting Cancer Mutated Genes.
    Fang J; Cai C; Wang Q; Lin P; Zhao Z; Cheng F
    CPT Pharmacometrics Syst Pharmacol; 2017 Mar; 6(3):177-187. PubMed ID: 28294568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Drug Response Profile scan (CDRscan): A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature.
    Chang Y; Park H; Yang HJ; Lee S; Lee KY; Kim TS; Jung J; Shin JM
    Sci Rep; 2018 Jun; 8(1):8857. PubMed ID: 29891981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RefDNN: a reference drug based neural network for more accurate prediction of anticancer drug resistance.
    Choi J; Park S; Ahn J
    Sci Rep; 2020 Feb; 10(1):1861. PubMed ID: 32024872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PATIENT-SPECIFIC DATA FUSION FOR CANCER STRATIFICATION AND PERSONALISED TREATMENT.
    Gligorijević V; Malod-Dognin N; Pržulj N
    Pac Symp Biocomput; 2016; 21():321-32. PubMed ID: 26776197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ConsensusDriver Improves upon Individual Algorithms for Predicting Driver Alterations in Different Cancer Types and Individual Patients.
    Bertrand D; Drissler S; Chia BK; Koh JY; Li C; Suphavilai C; Tan IB; Nagarajan N
    Cancer Res; 2018 Jan; 78(1):290-301. PubMed ID: 29259006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Personalization of Therapy: Molecular Profiling Technologies and Their Application.
    Zeron-Medina J; Ochoa de Olza M; Braña I; Rodon J
    Semin Oncol; 2015 Dec; 42(6):775-87. PubMed ID: 26615125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug repositioning in cancer: The current situation in Japan.
    Masuda T; Tsuruda Y; Matsumoto Y; Uchida H; Nakayama KI; Mimori K
    Cancer Sci; 2020 Apr; 111(4):1039-1046. PubMed ID: 31957175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.